Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

International Society on Thrombosis and Haemostasis - 34th Congress, 2026 (ISTH) 11 - 15 July 2026

A multinational, open-label study to investigate efficacy and safety of denecimig (Mim8) in adults with acquired haemophilia A: study enrolment 2026

Authors :

Andreas Tiede¹, Julien Bovet², Wan Hui Ong Clausen³, Rikke Meldgaard³, Valbona Meha⁴, Midori Shima⁵,Rebecca Kruse-Jarres⁶

Affiliations

View Details Hide Details

Keywords

Rare Blood Disorders

Congress poster

Mim8